维普期刊资源整合服务平台（V6.5）

41篇 您的检索式：作者名="Salgaller ML"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Dendritic cell-based immunotherapy of prostate cancer 显示文摘	TJOA BA LODGE PA	1998	Crit Rev Immunol1998，18，1：	1
2	Dendritic cell - based immunotherapy for prostate cancer 显示文摘	Tjoa BA Lodge PA Salgaller ML	1999	CA Cancer J Clin1999，49，2：	1
3	Current methods for loading dendritic cells with tumor antigen for the induction of antitumor immunity 显示文摘	Zhou Y Bosch ML Salgaller ML	2002	J Immunother2002，25，4：	1
4	Current methods for loading dendritic cells with tumor antigen for the induction of antitumor immunity显示文摘	Zhou Y Bosch ML Salgaller ML	2002	J Immunother2002，25，4：	1
5	Improved induction of melanoma-reactive CTL with peptides from the melanoma antigen gp100 modified at HLA-A*0201-binding residues 显示文摘	PARKHURST MR SALGALLER ML SOUTHWOOD S	1996	J Immunol1996，157，6：	1
6	Immunization against epitopes in the human melanoma antigen gp100 following patient immunization with synthetic peptides显示文摘	SALGALLER ML MARINCOLA FM CORMIER JN	1996	Cancer Res1996，56，20：	1
7	Dendritic cell-based immuntherapy of prostatecancer显示文摘	Salgaller ML Tjoa BA Lodger PA	1998	Crit Rev Immunol1998，18，12：	1
8	Dendritic xellbased immunotherapy of prostate cancer 显示文摘	SALGALLER ML TJOA BA LODGE PA	1998	Crit Rev Immunol1998，18，12：	1
9	Use of cellular and cytokine adju- vants in the immunotherapy of cancer显示文摘	Salgaller ML Lodge PA	1998	J Surg Oncol1998，68，2：	1
10	Progress in active-specific immunotherapy of brain malignancies 显示文摘	Tjoa BA Salgaller ML	2000	Expert Opin Investig Drugs2000，9，9：	1
11	Prostate cancer immunotherapy at the dawn of the new millennium显示文摘	Salgaller ML	2000	Expert Opin Investig Drugs2000，9，6：	1
12	Use of cellular and cytokine adjuvants in the immunotherapy of cancer显示文摘	SALGALLER ML LODGE PA	1998	J Surg Oncol1998，68，：	1
13	Current Methods for Loading Dendritic Cells with Tumor Antigen for the Induction of Antitumor Immunity显示文摘	Zhou Y Bosch ML Salgaller ML	2002	J Immunother2002，25，4：	1
14	Current methods for loading dendritic cells with tumor antigen for the induction of antitumor immunity显示文摘	Zhou Y Bosch ML Salgaller ML	2002	J immunother2002，25，4：	1
15	Technology evaluation: bevacizumab, Genentech/Roche显示文摘	SALGALLER ML	2003	Curr Opin Mol Ther2003，5，6：	1
16	Dendritic cell-based immunotherapy of prostate cancer显示文摘	Salgaller ML Tjoa BA Lodge PA	1998	Crit Rev Immunol1998，18，1：	1
17	Technology evaluation: bevacizumab, Genenteclg Roche显示文摘	Salgaller ML	2003	Curr Opin Mol Ther2003，5，6：	1
18	Dendritic cell-based immunotherapy of prostate cancer显示文摘	Tjoa BA Lodge PA	1998	Crit Rev Immunol1998，18，12：	1
19	Technology evaluation:bevacizumab,Genentech/Roche显示文摘	Salgaller ML		0，，06：	1
20	Enhancement of Cellular Immunity in Melanoma Patients Immunized with a Peptide from MART-1/Melan A显示文摘	Cormier JN Salgaller ML Prevette T etal	1997	Cancer J Sci Am1997，3，1：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示